The Effect of Postpartum Pelvic Floor Rehabilitation in Prevention and Treatment of Pelvic Floor Dysfunction
NCT ID: NCT01926314
Last Updated: 2013-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1000 participants
INTERVENTIONAL
2013-08-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
device
Patients in this group will be offered pelvic floor muscle rehabilitation program using PHENIX Neuromuscular Stimulation Therapy System device. The participants will start therapy once a week 42 days after delivery, and last 8 weeks.
PHENIX Neuromuscular Stimulation Therapy System device
usual home care without device
Patients in this group will receive usual home care without device.
usual home care without device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PHENIX Neuromuscular Stimulation Therapy System device
usual home care without device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* term delivery
* single childbirth
* aged from 18-50yrs
Exclusion Criteria
* fecal incontinence before pregnancy
* organ prolapse before pregnancy
* history of childbirth or induced labor with pregnancy more than 28 weeks
* multiparity
* newborn weight less than 2500 grams or more than 4000 grams
* precipitate labor
* complication of pregnancy
* asthma
* long-term abdominal pressure(chronic cough\>1 month,chronic constipation)
* diabetes
* sciatica
* history of pelvic operation
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking Union Medical College Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lan Zhu
Role: PRINCIPAL_INVESTIGATOR
Peking Union Medical College Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Foshan maternal and child health hospital
Foshan, Guangdong, China
The first affiliated hospital of Guangzhou medical college
Guangzhou, Guangdong, China
Wuxi Maternal and Child Health Hospital, Nanjing Medical University
Wuxi, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Lan Zhu
Role: primary
Yuling Wang
Role: primary
Xiaowei Zhang
Role: primary
Jian Gong
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
pumch-gyn-06
Identifier Type: -
Identifier Source: org_study_id